Malignant Hypertension Questions & Answers

1. Cremer A, Amraoui F, Lip GY, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens. 2016 Aug. 30(8):463-6. [QxMD MEDLINE Link].

2. Rodriguez MA, Kumar SK, De Caro M. Hypertensive crisis. Cardiol Rev. 2010 Mar-Apr. 18(2):102-7. [QxMD MEDLINE Link].

3. Pergolini MS. The management of hypertensive crises: a clinical review. Clin Ter. 2009 Mar-Apr. 160(2):151-7. [QxMD MEDLINE Link].

4. Polgreen LA, Suneja M, Tang F, Carter BL, Polgreen PM. Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States. Hypertension. 2015 May. 65(5):1002-7. [QxMD MEDLINE Link].

5. Patel A, Patel H, Patel A. Thrombotic thrombocytopenic purpura: the masquerader. South Med J. 2009 May. 102(5):504-9. [QxMD MEDLINE Link].

6. Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ. Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura. Ther Adv Hematol. 2015 Jun. 6(3):97-102. [QxMD MEDLINE Link].

7. Gonzalez R, Morales E, Segura J, Ruilope LM, Praga M. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant. 2010 Oct. 25(10):3266-72. [QxMD MEDLINE Link].

8. Lane DA, Lip GY, Beevers DG. Improving survival of malignant hypertension patients over 40 years. Am J Hypertens. 2009 Nov. 22(11):1199-204. [QxMD MEDLINE Link].

9. Amraoui F, Van Der Hoeven NV, Van Valkengoed IG, et al. Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study. J Clin Hypertens (Greenwich). 2014 Feb. 16(2):122-6. [QxMD MEDLINE Link].

10. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008 Jun. 51(6):1403-19. [QxMD MEDLINE Link].

11. Shukla D, Ramchandani B, Vignesh TP, Rajendran A, Neelakantan N. Localized serous retinal detachment of macula as a marker of malignant hypertension. Ophthalmic Surg Lasers Imaging. 2010 Mar 9. 1-7. [QxMD MEDLINE Link].

12. Lopes AA. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis. 2009 Spring. 19(1 Suppl 1):S1-47-51. [QxMD MEDLINE Link].

13. [Guideline] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the ACC/AHA Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun. 71(6):1269-324. [QxMD MEDLINE Link]. [Full Text].

14. Peacock WF, Varon J, Baumann BM, et al. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care. 2011. 15(3):R157. [QxMD MEDLINE Link].

15. Victor RG. Carotid baroreflex activation therapy for resistant hypertension. Nat Rev Cardiol. 2015 Aug. 12(8):451-63. [QxMD MEDLINE Link].

16. Chunbin W, Fu S, Jing H. Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis. Clin Exp Hypertens. 2018. 40(6):501-8. [QxMD MEDLINE Link].

17. [Guideline] Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013 Jul. 34(28):2159-219. [QxMD MEDLINE Link]. [Full Text].

18. [Guideline] Wolf SJ, Lo B, Shih RD, Smith MD, Fesmire FM, American College of Emergency Physicians Clinical Policies Committee. Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med. 2013 Jul. 62(1):59-68. [QxMD MEDLINE Link]. [Full Text].

John D Bisognano, MD, PhD, FACP, FACC Professor of Medicine, Director of Outpatient Cardiology, Department of Medicine, Cardiology Division, University of Rochester Medical Center

John D Bisognano, MD, PhD, FACP, FACC is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine

Disclosure: Nothing to disclose.

Vecihi Batuman, MD, FASN Professor of Medicine, Section of Nephrology-Hypertension, Deming Department of Medicine, Tulane University School of Medicine

Vecihi Batuman, MD, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

George R Aronoff, MD Director, Professor, Departments of Internal Medicine and Pharmacology, Section of Nephrology, Kidney Disease Program, University of Louisville School of Medicine

George R Aronoff, MD is a member of the following medical societies: American Federation for Medical Research, American Society of Nephrology, Kentucky Medical Association, and National Kidney Foundation

Disclosure: Nothing to disclose.

L Michael Prisant, MD, FACC, FAHA Cardiologist, Emeritus Professor of Medicine, Medical College of Georgia

L Michael Prisant, MD, FACC, FAHA is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Clinical Pharmacology, American College of Forensic Examiners, American College of Physicians, American Heart Association, and American Medical Association

Disclosure: Boehringer-Ingelheim Honoraria Speaking and teaching

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article